TrialHeadache2025

Comparative bioavailability of single-dose zavegepant during and between migraine attacks: A phase 1, randomized, open-label, fixed-sequence, two-period study.

Richard J Bertz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.